1. Int J Mol Sci. 2021 Feb 20;22(4):2113. doi: 10.3390/ijms22042113.

Molecular Regulation of Canalicular ABC Transporters.

Ben Saad A(1)(2), Bruneau A(2)(3), Mareux E(1), Lapalus M(1), Delaunay JL(2), 
Gonzales E(1)(4), Jacquemin E(1)(4), Aït-Slimane T(2), Falguières T(1).

Author information:
(1)Physiopathogénèse et Traitement des Maladies du foie, Inserm, Université 
Paris-Saclay, UMR_S 1193, Hepatinov, 91400 Orsay, France.
(2)Centre de Recherche Saint-Antoine (CRSA), Inserm, Sorbonne Université, UMR_S 
938, Institute of Cardiometabolism and Nutrition (ICAN), 75012 Paris, France.
(3)Department of Hepatology and Gastroenterology, Charité Universitäts Medizin 
Berlin, 13353 Berlin, Germany.
(4)Paediatric Hepatology and Paediatric Liver Transplant Department, Reference 
Center for Rare Paediatric Liver Diseases, FILFOIE, ERN RARE LIVER, Assistance 
Publique-Hôpitaux de Paris, Faculté de Médecine Paris-Saclay, CHU Bicêtre, 94270 
Le Kremlin-Bicêtre, France.

The ATP-binding cassette (ABC) transporters expressed at the canalicular 
membrane of hepatocytes mediate the secretion of several compounds into the bile 
canaliculi and therefore play a key role in bile secretion. Among these 
transporters, ABCB11 secretes bile acids, ABCB4 translocates phosphatidylcholine 
and ABCG5/G8 is responsible for cholesterol secretion, while ABCB1 and ABCC2 
transport a variety of drugs and other compounds. The dysfunction of these 
transporters leads to severe, rare, evolutionary biliary diseases. The 
development of new therapies for patients with these diseases requires a deep 
understanding of the biology of these transporters. In this review, we report 
the current knowledge regarding the regulation of canalicular ABC transporters' 
folding, trafficking, membrane stability and function, and we highlight the role 
of molecular partners in these regulating mechanisms.

DOI: 10.3390/ijms22042113
PMCID: PMC7924332
PMID: 33672718 [Indexed for MEDLINE]

Conflict of interest statement: The authors declare no conflict of interest.